Equity Brief: Ratings Changes for November 19th: PENN, PETM, PNNT, RMBS, SAP, SDT, SEP, SIRO, SU

2012-11-19 16:19:42 -

A number of stocks were upgraded and downgraded by equities research analysts

today, as reported by Analyst Ratings Network ( bit.ly/equitybriefdaily)

and Equity Brief:



Susquehanna raised its price target on shares of Penn National Gaming (NASDAQ:

PENN) from $49.00 to $57.00. They have a positive rating on the stock.



Barclays Capital upgraded shares of Petsmart Inc (NASDAQ: PETM) from an equal

weight rating to an overweight rating.



Robert W. Baird downgraded shares of PennantPark Investment Corp. (NASDAQ: PNNT)

from an outperform rating to a neutral rating. Their analysts now have a $11.00

price target on the stock, down previously from $12.00.



JPMorgan Chase upgraded shares of Rambus Inc. (NASDAQ: RMBS) from a neutral

rating to an overweight rating. JPMorgan Chase now has a $7.00 price target on

the stock. They wrote, "After falling 46% year-to-date (S&P 500 up 8.1%), we

think the stock, trading at trough-level multiples, is now largely de-risked. At

$4.00-$4.50 we think investors are limited from further downside by the value of

SBG contracted revenue (even withoutrenewals) plus cash on hand, and the break-

up value of the LED and CRI new businesses. We believe a potential settlement

with Hynix presents near-term upside for short-term investors."



William Blair upgraded shares of SAP Aktiengesellschaft (NYSE: SAP) from a

market perform rating to an outperform rating.



Raymond James upgraded shares of SandRidge Mississippian Trust I (SDT) from an

underperform rating to a market perform rating.



Citigroup upgraded shares of Spectra Energy Partners, LP (SEP) from a neutral

rating to a buy rating. Citigroup now has a $33.00 price target on the stock.



Stifel Nicolaus raised its price target on shares of Sirona Dental (SIRO) from

$68.00 to $72.00. They have a buy rating on the stock.



JPMorgan Chase upgraded shares of Suncor Energy Inc. (SU) from a neutral rating

to an overweight rating.



Aegis initiated coverage on shares of Trius Therapeutics Inc (TSRX). They issued

a buy rating on the stock and set a $15.00 price target.



Stay on top of analysts' coverage with Analyst Ratings Network's free daily

email newsletter that provides a concise list of analysts' upgrades, downgrades

and initiations. Register at  bit.ly/equitybriefdaily



Content and Media Contact: newseditor@equitybrief.net









This announcement is distributed by Thomson Reuters on behalf of 

Thomson Reuters clients. The owner of this announcement warrants that: 

(i) the releases contained herein are protected by copyright and 

    other applicable laws; and 

(ii) they are solely responsible for the content, accuracy and 

     originality of the information contained therein. 

    

Source: Equity Brief via Thomson Reuters ONE

[HUG#1659155]